256 Newsroom — Uganda's Digital News Infrastructure
Business

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients - CNBC

Published by CNBC By Annika Kim Constantino · 28 August 2026 at 00:49
Share
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients - CNBC
Image · CNBC

What the report says

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

Read the full report at CNBC →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Two Decades of Impact: How MSC Supported SAO Zirobwe SACCO is Transforming LuweeroSoftPower News From Scarcity to Scale: How MSC and Zebra SACCO are Changing the Lives of Young Men and Women in BomboSoftPower News Uganda’s first oil delayed yet again, new target pushed to June 2027The Observer How 256 Mall helps Ugandan businesses discover wholesale suppliers and request quotes online256 Mall AAYC chief Agaba mourns King Oyo as a friend, youth leadership iconWatchdog Uganda 256 Mall Export Hub puts Uganda’s export commodities into one clearer online marketplace256 Mall